A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

Overview of attention for article published in BMC Cancer, August 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 891 followers.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.